Serum concentrations of buprenorphine after oral and parenteral administration in male mice

Veterinary Journal

Volumn 187, Issue 2, 2011, Pages 251-254

  Kalliokoski, Otto ^a   Jacobsen, Kirsten R ^a   Hau, Jann ^a   Abelson, Klas S P ^a,b  

^a Mental Health Center Glostrup   (Denmark)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Analgesia; Buprenorphine; Kinetics; Refinement; Voluntary ingestion

Indexed keywords

BUPRENORPHINE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; EATING; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED STRAINS; PAIN; TIME FACTORS;

MUS; RODENTIA;

EID: 79951515245     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.11.013     Document Type: Article

References (19)

1. Christoph T., Kogel B., Schiene K., Meen M., De Vry J., Friderichs E. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. European Journal of Pharmacology 2005, 507:87-98.
2. Cirimele V., Etienne S., Villain M., Ludes B., Kintz P. Evaluation of the one-step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens. Forensic Science International 2004, 143:153-156.
3. Cowan A., Doxey J.C., Harry E.J.R. Animal pharmacology of buprenorphine, an oripavine analgesic agent. British Journal of Pharmacology 1977, 60:547-554.
4. Cowan A., Lewis J.W., Macfarlane I.R. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. British Journal of Pharmacology 1977, 60:537-545.
5. Dobromylskyj P., Flecknell P.A., Lascelles B.D., Pascoe P.J., Taylor P., Waterman-Pearson A. Management of postoperative and other acute pain. Pain Management in Animals 2000, 81-145. W.B. Saunders. P.A. Flecknell, A. Waterman-Pearson (Eds.).
6. Flecknell P.A. The relief of pain in laboratory animals. Laboratory Animals 1984, 18:147-160.
7. Flecknell P.A. Analgesia of small mammals. The Veterinary Clinics of North America. Exotic Animal Practice 2001, 4:47-56.
8. Flecknell P.A., Roughan J.V., Stewart R. Use of oral buprenorphine ('buprenorphine jello') for postoperative analgesia in rats - a clinical trial. Laboratory Animals 1999, 33:169-174.
9. Gades N.M., Danneman P.J., Wixson S.K., Tolley E.A. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemporary Topics in Laboratory Animal Science 2000, 39:8-13.
10. Goldkuhl R., Carlsson H.E., Hau J., Abelson K.S. Effect of subcutaneous injection and oral voluntary ingestion of buprenorphine on post-operative serum corticosterone levels in male rats. European Surgical Research 2008, 41:272-278.
11. Hedenqvist P., Hellebrekers L.J. Laboratory animal analgesia, anaesthesia, and euthanasia. Essential Principles and Practises 2003, vol. 1, second ed:413-455. CRC Press, Boca Raton. J. Hau, G.L. van Hoosier (Eds.).
12. Leander J.D. Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice. European Journal of Pharmacology 1988, 151:457-461.
13. Levitt M.D., Levitt D.G. Use of a two-compartment model to assess the pharmacokinetics of human ethanol metabolism. Alcoholism, Clinical and Experimental Research 1998, 22:1680-1688.
14. Martin L.B., Thompson A.C., Martin T., Kristal M.B. Analgesic efficacy of orally administered buprenorphine in rats. Comparative Medicine 2001, 51:43-48.
15. Ohtani M., Kotaki H., Uchino K., Sawada Y., Iga T. Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Drug Metabolism and Disposition: The Biological Fate of Chemicals 1994, 22:2-7.
16. Riegelman S., Rowland M. Effect of route of administration on drug disposition. Journal of Pharmacokinetics and Biopharmaceutics 1973, 1:419-434.
17. Roughan J.V., Flecknell P.A. Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Laboratory Animals 2002, 36:322-343.
18. Stokes E.L., Flecknell P.A., Richardson C.A. Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical procedures. Laboratory Animals 2009, 43:149-154.
19. Yu S., Zhang X., Sun Y., Peng Y., Johnson J., Mandrell T., Shukla A.J., Laizure S.C. Pharmacokinetics of buprenorphine after intravenous administration in the mouse. Journal of the American Association for Laboratory Animal Science 2006, 45:12-16.